Join
Live feed
·
PRReleasevia Quantisnow
Cerecor Inc. logo

Cerecor Announces Positive Initial Phase 1b Results for CERC-002 in Moderate to Severe Crohn's Disease Patients

ByQuantisnow·Wall Street's wire, on your screen.
CERC· Cerecor Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CERC (Cerecor Inc.) and more on Quantisnow.